Viral RNA quantification at 48 h post infection revealed significant inhibition of SFTSV replication by NbP45 or Tislelizumab compared to the untreated control, resulting in a reduction of viral RNA copies by more than 1.0 × 107 copies/ml (Fig. 5A). The gene discussed is HMGN5; the disease is infection.